North American cost analysis of brand name versus generic drugs for the treatment of glaucoma

BACKGROUND: According to the World Health Organization, glaucoma is a leading cause of irreversible blindness worldwide. By 2020, 80 million people will be affected by glaucoma in the world, which represents a significant financial burden to society. Glaucoma medications alone make up 38–52% of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Malvankar-Mehta, Monali S, Feng, Lucy, Hutnik, Cindy ML
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924989/
https://www.ncbi.nlm.nih.gov/pubmed/31908505
http://dx.doi.org/10.2147/CEOR.S156558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924989/
https://www.ncbi.nlm.nih.gov/pubmed/31908505
http://dx.doi.org/10.2147/CEOR.S156558

Ejemplares similares